Company profilePharmaceutical#99 of 1,318 in Pakistan1 DRAP alert

MEGA PHARMACEUTICALS (PVT) LTD

Pharmaceutical company · 161 brands · 161 molecules

Ranked #46 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

161 registered products 50 pharmaceutical brands 161 distinct molecules 1 DRAP alert

Company overview

161
registered products
50
pharmaceutical brands
161
distinct molecules
12
therapeutic classes
1
DRAP alerts

MEGA PHARMACEUTICALS (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 161 product registrations across 161 distinct molecules. It is the 99th largest registrant in Pakistan by product count, and ranks 46th of 311 in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Blood Glucose Lowering Drugs, Excluding Insulin. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by MEGA

91 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 3

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

89
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202589

Top molecules by brand count

Cefixime5 brands
Azithromycin5 brands
Linezolid4 brands
Amlodipine4 brands
Olanzapine4 brands
Ceftriaxone4 brands
Fexofenadine4 brands
Levofloxacin4 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 6Blood Glucose Lowering Drugs, Excluding Insulin · 4Quinolone Antibacterials · 4Lipid Modifying Agents · 4Antispasmodic & Anticholinergic · 3Angiotensin-Ii Antagonists, Combinations · 2Beta Blocking Agent · 2Vitamin C · 1Antiemetics & Antinauseants · 1Anti-Gout Preparations · 1Other Beta-Lactam, Cephalosporins & Penems · 1Antithrombotic Agents · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official157 products · Rs 41.38 – Rs 9,231.04
Median across source: Rs 399.17

Regulatory record

1 alert in the DRAP feed we track.

131. Recall Alert (Class-II) – DTLs Punjab Declared Substandard products.
2026-01-14

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Barrett Hodgson Pakistan (Private) Ltd. holds 144 molecules not in this portfolio
Acetylsalicylic AcidAtorvastatinBacitracinBacitracin AndlignocaineBambuterolBetahistine
BIO LABS (PVT) LTD. holds 113 molecules not in this portfolio
000 I.UAprepitantAremetherArtesunateAtorvastatinAzathioprine
GENOME PHARMACEUTICALS (PVT) LTD holds 89 molecules not in this portfolio
AcitretinAnastrazoleAnastrozoleAprepitantArtesunateBupropion

Get the full profile for MEGA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.